News of Note—HIV self test earns CE mark; Qiagen teams up on rare disease bioinformatics and more


> Sydney-based Atomo Diagnostics earned a CE mark for its HIV self test. Release | Read more from FierceMedTech

> Qiagen and Centogene are joining forces to offer more clinical testing solutions in rare genetic diseases. The partnership and comarketing agreement includes integrating the latter’s rare disease variant database into the former’s bioinformatics offerings. Release

> Siemens is partnering with lab equipment manufacturer Horiba Medical, to bring new laboratory hematology offerings to the global market. Release


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

> Finland’s Abacus Diagnostica has scored a CE mark for its rapid molecular test for the detection of norovirus. Release

> Olympus has signed on to distribute Ruhof Healthcare’s disposable endoscope valve set. The Guardian Endoscope Single-use Valve Set eliminates the need for cleaning, which can tamp down on hospital-acquired infections. Release | Read more about Olympus and its duodenoscopes

Suggested Articles

The FDA has cleared Drawbridge Health’s blood collection device designed to help monitor long-term blood sugar levels in people with diabetes.

FierceMedTech Fierce 15 winner 10x Genomics announced its plans for a $100 million IPO, on the Nasdaq using the symbol TXG.

Belgian devicemaker Miracor Medical received a breakthrough designation from the FDA for its treatment designed to limit the damage of a heart attack.